REVOLUTION Medicines logo

REVOLUTION Medicines Funding & Investors

Revolution Medicines, Inc. operates as an oncology company. The Company discovers novel targeted therapies to inhibit elusive frontier targets within notorious growth and survival pathways. Revolution Medicines serves customers worldwide.

revolutionmedicines.com

Total Amount Raised: $1,254,400,000

REVOLUTION Medicines Funding Rounds

  • Post Ipo Equity

    $323,600,000

  • Post Ipo Equity

    $264,500,000

  • Post Ipo Equity

    $260,900,000

  • Post Ipo Equity

    $179,400,000

  • Series C

    $100,000,000

    Series C Investors

    Boxer Capital
    Column Group
    Fidelity Investments
    Third Rock Ventures
    Deerfield Capital Management
    Biotechnology Value Fund
    Vivo Capital
    Casdin Capital
    Cormorant Capital
    Schroder Adveq
    Nextech Invest
  • Series B

    $56,000,000

    Series B Investors

    Nextech Invest
    Casdin Capital
    Column Group
    Third Rock Ventures
    Schroder Adveq
  • Series A

    $25,000,000

    Series A Investors

    Column Group
    Third Rock Ventures
  • Series A

    $45,000,000

    Series A Investors

    Third Rock Ventures
  • IPO

    Unknown

Funding info provided by Diffbot.